Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting

Volumn 35, Issue , 2016, Pages 67-73

  Kluetz, Paul G ^a   Chingos, Diana T ^a   Basch, Ethan M ^a   Mitchell, Sandra A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FOOD AND DRUG ADMINISTRATION; HUMAN; NATIONAL HEALTH ORGANIZATION; NEOPLASMS; PATHOLOGY; PATIENT-REPORTED OUTCOME; SELF REPORT; UNITED STATES;

ANTINEOPLASTIC AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PATIENT REPORTED OUTCOME MEASURES; SELF REPORT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84995463940     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.14694/EDBK_159514     Document Type: Review

References (0)